Applications

• DNA from whole blood (human or animal blood, fresh or frozen)
• DNA from whole blood treated with citrate, EDTA, heparin, CPDA
• DNA from serum, plasma, buffy coat, platelets, body fluids (e.g., amniotic fluid)
• DNA from cultured cells
• Typical downstream applications: PCR, Southern blotting, enzymatic reactions

Features

• Ready-to-use DNA in less than 60 min
• Complete removal of PCR inhibitors
• Suitable for whole blood, treated with citrate, EDTA, heparin, CPDA
• Consistently high DNA yields

Specifications

• Technology: Silica membrane technology

NucleoSpin® Blood L

• Processing: Centrifugation*
• Sample material: Blood (0.2–2 mL), human / animal cells (2 x 10⁷)
• Fragment size: 200 bp–approx. 50 kbp
• Typical yield: 40–60 μg (2 mL blood)
• Elution volume: 120–200 μL
• Binding capacity: 250 μg
• Processing time: 60 min/prep

NucleoSpin® Blood XL

• Processing: Centrifugation*
• Sample material: Blood (2–10 mL), human / animal cells (10⁸)
• Fragment size: 200 bp–approx. 50 kbp
• Typical yield: 200–300 μg (10 mL blood)
• Elution volume: 600–2000 μL
• Binding capacity: 700 μg
• Processing time: 60 min/prep